{"id":11259,"global_id":"bio-pat.org\/en?id=11259","global_id_lineage":["bio-pat.org\/en?id=11259"],"author":"3","status":"publish","date":"2024-08-23 10:39:19","date_utc":"2024-08-23 09:39:19","modified":"2024-09-13 16:55:38","modified_utc":"2024-09-13 15:55:38","url":"https:\/\/bio-pat.org\/en\/event\/knauer-at-lnp-development-summit","rest_url":"https:\/\/bio-pat.org\/en\/wp-json\/tribe\/events\/v1\/events\/11259","title":"KNAUER at LNP Development Summit Europe","description":"
\n\t

\n\t\t\n\t\t\t\t\t<\/span>\n\n\t\t\t\t\t\n\t\t\t\t; \t\t\t<\/span>\n\t\t\t\n\t\t\t\t\t\t\t<\/span>\n\t\t\n\t\t\t<\/p>\n<\/div>\n\n\n\n

KNAUER at LNP Development Summit Europe<\/strong><\/p>\n\n\n\n

\"KNAUER<\/figure>\n\n\n\n

KNAUER will attend the summit. Get in touch with the colleagues to learn more about the possibilities of LNP production systems.<\/strong><\/p>\n\n\n\n

About the conference<\/strong><\/p>\n\n\n\n

Empower LNP Development with Advanced Screening, Translatable Models, and Precision Characterisation, Crafting Potent LNPs for Diverse Therapeutic Needs and Payloads<\/p>\n\n\n\n

The spotlight continues to shine on lipid nanoparticles as the \u2018go-to\u2019 delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications<\/strong>. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable<\/strong>. Pinpoint the lipid components and structural complexities, advance formulative strategy and streamline manufacture to revolutionise your LNP design.<\/p>\n\n\n\n

The 3rd Lipid Nanoparticles Development Summit Europe<\/a> <\/strong>is your leading forum to unite as a driven community of leaders, forcing lipid nanoparticle innovative design and manufacture into the centre of the conversation, demanding more clinical progress and regulatory approval across a wide range of payloads<\/strong>. Spotlight the challenges impacting discovery<\/strong>, formulation<\/strong>, characterization<\/strong> and manufacturing<\/strong> teams across Europe and beyond in a bid to create novel lipid nanoparticles.<\/p>\n\n\n\n

Industry leaders are gathering in Berlin this September to bring the greatest challenges in LNP development to the fore, tackling them head on to ensure 2024 is the year of the LNP.
Join them this September address your unanswered questions and drive your development of LNPs to the next level, supercharging innovation in your approach to safe, stable and targeted drug delivery.<\/p>\n\n\n\n

With an agenda developed following consultative discussion with the field\u2019s biggest players, GSK<\/strong>, J&J<\/strong>, CureVac<\/strong> and more, this summit is of highest value for the community to receive end-to-end LNP insights. Development roadblocks such as lipid characterisation<\/strong>, model translatability<\/strong>, toxicity occurrence<\/strong>, targeted delivery<\/strong> form core parts of the discussion, delivered from world-leading speakers across pharma, biotech and academia.<\/p>\n\n\n\n

Agenda<\/a>
Speakers<\/a>
Registration<\/a><\/p>\n\n\n\n

KNAUER Wissenschaftliche Ger\u00e4te GmbH<\/a> is a member of the network Bio-PAT<\/a>.<\/p>\n\n\n

\n\t\t<\/div>\n\n\n
\n\t
\n\t\t

Organizer: Hanson Wade<\/h3>\n\t<\/div>\n\t\t\t\t\t

info@hansonwade.com<\/p>\n\t<\/div>\n\n\n

\n\t\n\t\t\n\t<\/div>\n\n\n\n\n\t
\n\t\t
\n\t\t\t